desvenlafaxine-succinate and Myocardial-Infarction

desvenlafaxine-succinate has been researched along with Myocardial-Infarction* in 2 studies

Other Studies

2 other study(ies) available for desvenlafaxine-succinate and Myocardial-Infarction

ArticleYear
Cognitive Deficits Following a Post-Myocardial Infarct in the Rat Are Blocked by the Serotonin-Norepinephrine Reuptake Inhibitor Desvenlafaxine.
    International journal of molecular sciences, 2018, Nov-26, Volume: 19, Issue:12

    Myocardial infarction (MI) in animal models induces cognitive deficits as well as the activation of caspase in the limbic system; both can be blocked by 2 weeks of treatment following MI using tricyclic antidepressants or selective serotonin uptake blockers. Here we used three different treatment schedules to test the short- and long-term effects of the combined serotonin-norepinephrine reuptake inhibitor desvenlafaxine on post-MI-associated cognitive deficits and caspase activation. MI was induced in 39 young adult rats, and 39 rats served as sham-operated controls. Desvenlafaxine (3 mg/kg/day, i.p.) or saline was administered according to one of three schedules: (1) for 2 weeks, starting right after surgery; (2) for 16 weeks, starting 2 weeks after surgery; (3) for 16 weeks, starting right after surgery. Behavior was tested 2 weeks (social interaction, passive avoidance) and 16 weeks (forced swimming, Morris water maze) after surgery. Caspase-3 and caspase-6 activities were measured 16 weeks after surgery. At 2 and 16 weeks post-surgery, saline-treated MI rats displayed performance deficits compared to desvenlafaxine-treated rats, regardless of the treatment schedule. Caspase-3 activity was higher in the amygdala (medial and lateral) and hippocampal CA3 region in untreated MI rats, whereas caspase-6 activity was higher in the CA1 region. Caspase-6 activity correlated positively with deficits in the Morris water maze. These results indicate that, independently of treatment schedules, various treatment schedules with desvenlafaxine can prevent MI-associated cognitive deficits and decrease caspase activities in the limbic system.

    Topics: Animals; Avoidance Learning; Behavior, Animal; Caspases; Cicatrix; Cognition Disorders; Desvenlafaxine Succinate; Male; Maze Learning; Myocardial Infarction; Norepinephrine; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Social Behavior; Spatial Memory; Swimming

2018
Desvenlafaxine reduces apoptosis in amygdala after myocardial infarction.
    Brain research bulletin, 2014, Volume: 109

    This study was designed to determine if desvenlafaxine (DV), a serotonin-norepinephrine reuptake inhibitor, can attenuate apoptosis observed in the limbic system after myocardial infarction (MI). MI was induced in rats by occlusion of the left descending artery for 40 min followed by reperfusion. Another group of sham (control) rats was similarly manipulated, but without occlusion. Half of the full cohort received DV (3 mg/kg/day intraperitoneal), starting 5 min after the onset of reperfusion; the other half received the vehicle (0.5 ml of 0.9% saline). Rats were sacrificed after 3 days for biochemical analyses and MI size measurements. Infarct size was significantly smaller in DV- compared to vehicle-treated rats. At 3 days post-MI, caspase-3 and -8 activities and terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling-positive cells were decreased in the amygdala of DV-treated rats compared to MI-vehicle controls. No difference was observed between the sham groups. The data indicates that DV given immediately after an acute MI event can reduce MI size and apoptosis in amygdala when measured three days post-MI.

    Topics: Amygdala; Analysis of Variance; Animals; Apoptosis; Caspase 3; Caspase 8; Cyclohexanols; Desvenlafaxine Succinate; Disease Models, Animal; In Situ Nick-End Labeling; Male; Myocardial Infarction; Neurotransmitter Uptake Inhibitors; Rats; Rats, Sprague-Dawley; Reperfusion; Statistics as Topic

2014